NEWS
24 2 OCTOBER 2020 • VOL 370 ISSUE 6512 sciencemag.org SCIENCE
ILLUSTRATION: STEPHAN SCHMITZA Science investigation shows that FDA oversight of clinical trials is lax,
slow moving, and secretive—and that enforcement is declining
By Charles Piller
OFFICIAL INACTION
FEATURES